Unicycive Therapeutics (UNCY) Net Income towards Common Stockholders (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Unicycive Therapeutics | 181.94 Mn | 127.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.57% |
| Dec 31, 2025 | -144.02% |
| Sep 30, 2025 | 6.76% |
| Jun 30, 2025 | -1,364.12% |
| Mar 31, 2025 | 102.37% |
| Dec 31, 2024 | -425.51% |
| Sep 30, 2024 | -234.60% |
| Jun 30, 2024 | 114.37% |
| Mar 31, 2024 | -171.49% |
| Dec 31, 2023 | -77.03% |
| Sep 30, 2023 | 0.81% |
| Jun 30, 2023 | 69.93% |
| Mar 31, 2023 | -177.16% |
| Dec 31, 2022 | 4.12% |
| Sep 30, 2022 | -52.83% |
| Jun 30, 2022 | -2.80% |
| Mar 31, 2022 | -28.52% |
| Dec 31, 2021 | 47.09% |
| Sep 30, 2021 | -372.82% |
| Jun 30, 2021 | -11.90% |
| Mar 31, 2021 | -11.70% |
| Dec 31, 2020 | -25.36% |
| Sep 30, 2020 | -107.69% |